Bioterrorism Vaccine Delivery Device Maker Gets DoD Contract
This article was originally published in The Gray Sheet
Executive Summary
Ichor Medical Systems, maker of a novel system for delivery of DNA-based drugs and vaccines, signed a two-year contract with the Navy worth over $2.3 million to assist in developing a DNA vaccine for anthrax and plague
You may also be interested in...
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.